APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Enalapril

Compare research editions
View pricing & licenses

Selected research

Industry Research

Enalapril Industry Research Report 2026

31 December 2025139 pages

Choose your research edition.

Industry ResearchEnalapril Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Enalapril Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Enalapril Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enalapril Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Enalapril Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Enalapril market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Enalapril is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Enalapril is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Enalapril include Wockhardt Americas Inc, Watson Laboratories Inc, Teva Pharmaceuticals Usa Inc, Teva Parenteral Medicines Inc, Taro Pharmaceutical Industries Ltd, Sandoz Inc, Ranbaxy Laboratories Ltd, Mylan Pharmaceuticals Inc and Lek Pharmaceuticals D D, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Enalapril market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Enalapril Market by Company

Wockhardt Americas Inc

Watson Laboratories Inc

Teva Pharmaceuticals Usa Inc

Teva Parenteral Medicines Inc

Taro Pharmaceutical Industries Ltd

Sandoz Inc

Ranbaxy Laboratories Ltd

Mylan Pharmaceuticals Inc

Lek Pharmaceuticals D D

Krka Dd Novo Mesto

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa

Hospira Inc

Hikma Farmaceutica (Portugal) Sa

Biovail Laboratories International Srl

Bedford Laboratories Div Ben Venue Laboratories Inc

Apothecon Inc Div Bristol Myers Squibb

Apotex Inc

Enalapril Segment by Type

10mg

2.5mg

20mg

5mg

Enalapril Segment by Application

Hospital

Drugs Store

Enalapril Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enalapril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enalapril and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enalapril.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Enalapril manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Enalapril by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Enalapril in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Enalapril Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Enalapril Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Enalapril Sales Market Share by Manufacturers (2021-2026) Table 8. Global Enalapril Revenue of Manufacturers (2021-2026) Table 9. Global Enalapril Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Enalapril Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Enalapril Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Enalapril, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Enalapril, Product Type & Application Table 14. Global Enalapril Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Enalapril by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Wockhardt Americas Inc Company Information Table 19. Wockhardt Americas Inc Business Overview Table 20. Wockhardt Americas Inc Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Wockhardt Americas Inc Enalapril Product Portfolio Table 22. Wockhardt Americas Inc Recent Developments Table 23. Watson Laboratories Inc Company Information Table 24. Watson Laboratories Inc Business Overview Table 25. Watson Laboratories Inc Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Watson Laboratories Inc Enalapril Product Portfolio Table 27. Watson Laboratories Inc Recent Developments Table 28. Teva Pharmaceuticals Usa Inc Company Information Table 29. Teva Pharmaceuticals Usa Inc Business Overview Table 30. Teva Pharmaceuticals Usa Inc Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Teva Pharmaceuticals Usa Inc Enalapril Product Portfolio Table 32. Teva Pharmaceuticals Usa Inc Recent Developments Table 33. Teva Parenteral Medicines Inc Company Information Table 34. Teva Parenteral Medicines Inc Business Overview Table 35. Teva Parenteral Medicines Inc Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Teva Parenteral Medicines Inc Enalapril Product Portfolio Table 37. Teva Parenteral Medicines Inc Recent Developments Table 38. Taro Pharmaceutical Industries Ltd Company Information Table 39. Taro Pharmaceutical Industries Ltd Business Overview Table 40. Taro Pharmaceutical Industries Ltd Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Taro Pharmaceutical Industries Ltd Enalapril Product Portfolio Table 42. Taro Pharmaceutical Industries Ltd Recent Developments Table 43. Sandoz Inc Company Information Table 44. Sandoz Inc Business Overview Table 45. Sandoz Inc Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Sandoz Inc Enalapril Product Portfolio Table 47. Sandoz Inc Recent Developments Table 48. Ranbaxy Laboratories Ltd Company Information Table 49. Ranbaxy Laboratories Ltd Business Overview Table 50. Ranbaxy Laboratories Ltd Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Ranbaxy Laboratories Ltd Enalapril Product Portfolio Table 52. Ranbaxy Laboratories Ltd Recent Developments Table 53. Mylan Pharmaceuticals Inc Company Information Table 54. Mylan Pharmaceuticals Inc Business Overview Table 55. Mylan Pharmaceuticals Inc Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Mylan Pharmaceuticals Inc Enalapril Product Portfolio Table 57. Mylan Pharmaceuticals Inc Recent Developments Table 58. Lek Pharmaceuticals D D Company Information Table 59. Lek Pharmaceuticals D D Business Overview Table 60. Lek Pharmaceuticals D D Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Lek Pharmaceuticals D D Enalapril Product Portfolio Table 62. Lek Pharmaceuticals D D Recent Developments Table 63. Krka Dd Novo Mesto Company Information Table 64. Krka Dd Novo Mesto Business Overview Table 65. Krka Dd Novo Mesto Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Krka Dd Novo Mesto Enalapril Product Portfolio Table 67. Krka Dd Novo Mesto Recent Developments Table 68. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Company Information Table 69. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Business Overview Table 70. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Product Portfolio Table 72. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Recent Developments Table 73. Hospira Inc Company Information Table 74. Hospira Inc Business Overview Table 75. Hospira Inc Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hospira Inc Enalapril Product Portfolio Table 77. Hospira Inc Recent Developments Table 78. Hikma Farmaceutica (Portugal) Sa Company Information Table 79. Hikma Farmaceutica (Portugal) Sa Business Overview Table 80. Hikma Farmaceutica (Portugal) Sa Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hikma Farmaceutica (Portugal) Sa Enalapril Product Portfolio Table 82. Hikma Farmaceutica (Portugal) Sa Recent Developments Table 83. Biovail Laboratories International Srl Company Information Table 84. Biovail Laboratories International Srl Business Overview Table 85. Biovail Laboratories International Srl Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Biovail Laboratories International Srl Enalapril Product Portfolio Table 87. Biovail Laboratories International Srl Recent Developments Table 88. Bedford Laboratories Div Ben Venue Laboratories Inc Company Information Table 89. Bedford Laboratories Div Ben Venue Laboratories Inc Business Overview Table 90. Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Product Portfolio Table 92. Bedford Laboratories Div Ben Venue Laboratories Inc Recent Developments Table 93. Apothecon Inc Div Bristol Myers Squibb Company Information Table 94. Apothecon Inc Div Bristol Myers Squibb Business Overview Table 95. Apothecon Inc Div Bristol Myers Squibb Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Apothecon Inc Div Bristol Myers Squibb Enalapril Product Portfolio Table 97. Apothecon Inc Div Bristol Myers Squibb Recent Developments Table 98. Apotex Inc Company Information Table 99. Apotex Inc Business Overview Table 100. Apotex Inc Enalapril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Apotex Inc Enalapril Product Portfolio Table 102. Apotex Inc Recent Developments Table 103. Global Enalapril Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Enalapril Sales by Region (2021-2026) & (K Units) Table 105. Global Enalapril Sales Market Share by Region (2021-2026) Table 106. Global Enalapril Sales by Region (2027-2032) & (K Units) Table 107. Global Enalapril Sales Market Share by Region (2027-2032) Table 108. Global Enalapril Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Enalapril Revenue Market Share by Region (2021-2026) Table 110. Global Enalapril Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Enalapril Revenue Market Share by Region (2027-2032) Table 112. North America Enalapril Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Enalapril Sales by Country (2021-2026) & (K Units) Table 114. North America Enalapril Sales by Country (2027-2032) & (K Units) Table 115. North America Enalapril Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Enalapril Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Enalapril Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Enalapril Sales by Country (2021-2026) & (K Units) Table 119. Europe Enalapril Sales by Country (2027-2032) & (K Units) Table 120. Europe Enalapril Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Enalapril Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Enalapril Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Enalapril Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Enalapril Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Enalapril Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Enalapril Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Enalapril Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Enalapril Sales by Country (2021-2026) & (K Units) Table 129. South America Enalapril Sales by Country (2027-2032) & (K Units) Table 130. South America Enalapril Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Enalapril Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Enalapril Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Enalapril Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Enalapril Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Enalapril Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Enalapril Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Enalapril Sales by Type (2021-2026) & (K Units) Table 138. Global Enalapril Sales by Type (2027-2032) & (K Units) Table 139. Global Enalapril Sales Market Share by Type (2021-2026) Table 140. Global Enalapril Sales Market Share by Type (2027-2032) Table 141. Global Enalapril Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Enalapril Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Enalapril Revenue Market Share by Type (2021-2026) Table 144. Global Enalapril Revenue Market Share by Type (2027-2032) Table 145. Global Enalapril Price by Type (2021-2026) & (US$/Unit) Table 146. Global Enalapril Price by Type (2027-2032) & (US$/Unit) Table 147. Global Enalapril Sales by Application (2021-2026) & (K Units) Table 148. Global Enalapril Sales by Application (2027-2032) & (K Units) Table 149. Global Enalapril Sales Market Share by Application (2021-2026) Table 150. Global Enalapril Sales Market Share by Application (2027-2032) Table 151. Global Enalapril Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Enalapril Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Enalapril Revenue Market Share by Application (2021-2026) Table 154. Global Enalapril Revenue Market Share by Application (2027-2032) Table 155. Global Enalapril Price by Application (2021-2026) & (US$/Unit) Table 156. Global Enalapril Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Enalapril Distributors List Table 160. Enalapril Customers List Table 161. Enalapril Industry Trends Table 162. Enalapril Industry Drivers Table 163. Enalapril Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Enalapril Product Image Figure 5. Global Enalapril Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Enalapril Market Size (2021-2032) & (US$ Million) Figure 7. Global Enalapril Sales (2021-2032) & (K Units) Figure 8. Global Enalapril Average Price (US$/Unit) & (2021-2032) Figure 9. 10mg Product Image Figure 10. 2.5mg Product Image Figure 11. 20mg Product Image Figure 12. 5mg Product Image Figure 13. Hospital Product Image Figure 14. Drugs Store Product Image Figure 15. Global Enalapril Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Enalapril, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Enalapril Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Enalapril Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Enalapril Sales by Region in 2025 Figure 21. Global Enalapril Revenue by Region in 2025 Figure 22. North America Enalapril Market Size by Country in 2025 Figure 23. North America Enalapril Sales Market Share by Country (2021-2032) Figure 24. North America Enalapril Revenue Market Share by Country (2021-2032) Figure 25. United States Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Enalapril Market Size by Country in 2025 Figure 28. Europe Enalapril Sales Market Share by Country (2021-2032) Figure 29. Europe Enalapril Revenue Market Share by Country (2021-2032) Figure 30. Germany Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific Enalapril Market Size by Country in 2025 Figure 36. Asia Pacific Enalapril Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific Enalapril Revenue Market Share by Country (2021-2032) Figure 38. China Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America Enalapril Market Size by Country in 2025 Figure 47. South America Enalapril Sales Market Share by Country (2021-2032) Figure 48. South America Enalapril Revenue Market Share by Country (2021-2032) Figure 49. Mexico Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Enalapril Market Size by Country in 2025 Figure 53. Middle East and Africa Enalapril Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Enalapril Revenue Market Share by Country (2021-2032) Figure 55. Turkey Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Enalapril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Enalapril Sales Market Share by Type (2021-2032) Figure 59. Global Enalapril Revenue Market Share by Type (2021-2032) Figure 60. Global Enalapril Price (US$/Unit) by Type (2021-2032) Figure 61. Global Enalapril Sales Market Share by Application (2021-2032) Figure 62. Global Enalapril Revenue Market Share by Application (2021-2032) Figure 63. Global Enalapril Price (US$/Unit) by Application (2021-2032) Figure 64. Enalapril Value Chain Figure 65. Enalapril Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Enalapril Industry Opportunities and Challenges

Scope & coverage.

Types
  • 10mg
  • 2.5mg
  • 20mg
  • 5mg
Applications
  • Hospital
  • Drugs Store
Companies covered
  • Wockhardt Americas Inc
  • Watson Laboratories Inc
  • Teva Pharmaceuticals Usa Inc
  • Teva Parenteral Medicines Inc
  • Taro Pharmaceutical Industries Ltd
  • Sandoz Inc
  • Ranbaxy Laboratories Ltd
  • Mylan Pharmaceuticals Inc
  • Lek Pharmaceuticals D D
  • Krka Dd Novo Mesto
  • Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
  • Hospira Inc
  • Hikma Farmaceutica (Portugal) Sa
  • Biovail Laboratories International Srl
  • Bedford Laboratories Div Ben Venue Laboratories Inc
  • Apothecon Inc Div Bristol Myers Squibb
  • Apotex Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Enalapril Market Size (2021-2032)
  4. 2.2.2 Global Enalapril Sales (2021-2032)
  5. 2.2.3 Global Enalapril Market Average Price (2021-2032)
  6. 2.3 Enalapril by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 10mg
  9. 2.3.3 2.5mg
  10. 2.3.4 20mg
  11. 2.3.5 5mg
  12. 2.4 Enalapril by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 Drugs Store
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Enalapril Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Enalapril Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Enalapril Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Enalapril Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Enalapril Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Enalapril, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Enalapril, Product Type & Application
  8. 3.8 Global Manufacturers of Enalapril, Established Date
  9. 3.9 Global Enalapril Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Wockhardt Americas Inc
  2. 4.1.1 Wockhardt Americas Inc Company Information
  3. 4.1.2 Wockhardt Americas Inc Business Overview
  4. 4.1.3 Wockhardt Americas Inc Enalapril Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Wockhardt Americas Inc Enalapril Product Portfolio
  6. 4.1.5 Wockhardt Americas Inc Recent Developments
  7. 4.2 Watson Laboratories Inc
  8. 4.2.1 Watson Laboratories Inc Company Information
  9. 4.2.2 Watson Laboratories Inc Business Overview
  10. 4.2.3 Watson Laboratories Inc Enalapril Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Watson Laboratories Inc Enalapril Product Portfolio
  12. 4.2.5 Watson Laboratories Inc Recent Developments
  13. 4.3 Teva Pharmaceuticals Usa Inc
  14. 4.3.1 Teva Pharmaceuticals Usa Inc Company Information
  15. 4.3.2 Teva Pharmaceuticals Usa Inc Business Overview
  16. 4.3.3 Teva Pharmaceuticals Usa Inc Enalapril Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Teva Pharmaceuticals Usa Inc Enalapril Product Portfolio
  18. 4.3.5 Teva Pharmaceuticals Usa Inc Recent Developments
  19. 4.4 Teva Parenteral Medicines Inc
  20. 4.4.1 Teva Parenteral Medicines Inc Company Information
  21. 4.4.2 Teva Parenteral Medicines Inc Business Overview
  22. 4.4.3 Teva Parenteral Medicines Inc Enalapril Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Teva Parenteral Medicines Inc Enalapril Product Portfolio
  24. 4.4.5 Teva Parenteral Medicines Inc Recent Developments
  25. 4.5 Taro Pharmaceutical Industries Ltd
  26. 4.5.1 Taro Pharmaceutical Industries Ltd Company Information
  27. 4.5.2 Taro Pharmaceutical Industries Ltd Business Overview
  28. 4.5.3 Taro Pharmaceutical Industries Ltd Enalapril Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Taro Pharmaceutical Industries Ltd Enalapril Product Portfolio
  30. 4.5.5 Taro Pharmaceutical Industries Ltd Recent Developments
  31. 4.6 Sandoz Inc
  32. 4.6.1 Sandoz Inc Company Information
  33. 4.6.2 Sandoz Inc Business Overview
  34. 4.6.3 Sandoz Inc Enalapril Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Sandoz Inc Enalapril Product Portfolio
  36. 4.6.5 Sandoz Inc Recent Developments
  37. 4.7 Ranbaxy Laboratories Ltd
  38. 4.7.1 Ranbaxy Laboratories Ltd Company Information
  39. 4.7.2 Ranbaxy Laboratories Ltd Business Overview
  40. 4.7.3 Ranbaxy Laboratories Ltd Enalapril Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Ranbaxy Laboratories Ltd Enalapril Product Portfolio
  42. 4.7.5 Ranbaxy Laboratories Ltd Recent Developments
  43. 4.8 Mylan Pharmaceuticals Inc
  44. 4.8.1 Mylan Pharmaceuticals Inc Company Information
  45. 4.8.2 Mylan Pharmaceuticals Inc Business Overview
  46. 4.8.3 Mylan Pharmaceuticals Inc Enalapril Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Mylan Pharmaceuticals Inc Enalapril Product Portfolio
  48. 4.8.5 Mylan Pharmaceuticals Inc Recent Developments
  49. 4.9 Lek Pharmaceuticals D D
  50. 4.9.1 Lek Pharmaceuticals D D Company Information
  51. 4.9.2 Lek Pharmaceuticals D D Business Overview
  52. 4.9.3 Lek Pharmaceuticals D D Enalapril Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Lek Pharmaceuticals D D Enalapril Product Portfolio
  54. 4.9.5 Lek Pharmaceuticals D D Recent Developments
  55. 4.10 Krka Dd Novo Mesto
  56. 4.10.1 Krka Dd Novo Mesto Company Information
  57. 4.10.2 Krka Dd Novo Mesto Business Overview
  58. 4.10.3 Krka Dd Novo Mesto Enalapril Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Krka Dd Novo Mesto Enalapril Product Portfolio
  60. 4.10.5 Krka Dd Novo Mesto Recent Developments
  61. 4.11 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
  62. 4.11.1 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Company Information
  63. 4.11.2 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Business Overview
  64. 4.11.3 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Product Portfolio
  66. 4.11.5 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Recent Developments
  67. 4.12 Hospira Inc
  68. 4.12.1 Hospira Inc Company Information
  69. 4.12.2 Hospira Inc Business Overview
  70. 4.12.3 Hospira Inc Enalapril Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hospira Inc Enalapril Product Portfolio
  72. 4.12.5 Hospira Inc Recent Developments
  73. 4.13 Hikma Farmaceutica (Portugal) Sa
  74. 4.13.1 Hikma Farmaceutica (Portugal) Sa Company Information
  75. 4.13.2 Hikma Farmaceutica (Portugal) Sa Business Overview
  76. 4.13.3 Hikma Farmaceutica (Portugal) Sa Enalapril Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hikma Farmaceutica (Portugal) Sa Enalapril Product Portfolio
  78. 4.13.5 Hikma Farmaceutica (Portugal) Sa Recent Developments
  79. 4.14 Biovail Laboratories International Srl
  80. 4.14.1 Biovail Laboratories International Srl Company Information
  81. 4.14.2 Biovail Laboratories International Srl Business Overview
  82. 4.14.3 Biovail Laboratories International Srl Enalapril Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Biovail Laboratories International Srl Enalapril Product Portfolio
  84. 4.14.5 Biovail Laboratories International Srl Recent Developments
  85. 4.15 Bedford Laboratories Div Ben Venue Laboratories Inc
  86. 4.15.1 Bedford Laboratories Div Ben Venue Laboratories Inc Company Information
  87. 4.15.2 Bedford Laboratories Div Ben Venue Laboratories Inc Business Overview
  88. 4.15.3 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Product Portfolio
  90. 4.15.5 Bedford Laboratories Div Ben Venue Laboratories Inc Recent Developments
  91. 4.16 Apothecon Inc Div Bristol Myers Squibb
  92. 4.16.1 Apothecon Inc Div Bristol Myers Squibb Company Information
  93. 4.16.2 Apothecon Inc Div Bristol Myers Squibb Business Overview
  94. 4.16.3 Apothecon Inc Div Bristol Myers Squibb Enalapril Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Apothecon Inc Div Bristol Myers Squibb Enalapril Product Portfolio
  96. 4.16.5 Apothecon Inc Div Bristol Myers Squibb Recent Developments
  97. 4.17 Apotex Inc
  98. 4.17.1 Apotex Inc Company Information
  99. 4.17.2 Apotex Inc Business Overview
  100. 4.17.3 Apotex Inc Enalapril Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Apotex Inc Enalapril Product Portfolio
  102. 4.17.5 Apotex Inc Recent Developments
5 Global Enalapril Market Scenario by Region
  1. 5.1 Global Enalapril Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Enalapril Sales by Region: 2021-2032
  3. 5.2.1 Global Enalapril Sales by Region: 2021-2026
  4. 5.2.2 Global Enalapril Sales by Region: 2027-2032
  5. 5.3 Global Enalapril Revenue by Region: 2021-2032
  6. 5.3.1 Global Enalapril Revenue by Region: 2021-2026
  7. 5.3.2 Global Enalapril Revenue by Region: 2027-2032
  8. 5.4 North America Enalapril Market Facts & Figures by Country
  9. 5.4.1 North America Enalapril Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Enalapril Sales by Country (2021-2032)
  11. 5.4.3 North America Enalapril Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Enalapril Market Facts & Figures by Country
  15. 5.5.1 Europe Enalapril Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Enalapril Sales by Country (2021-2032)
  17. 5.5.3 Europe Enalapril Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Enalapril Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Enalapril Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Enalapril Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Enalapril Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Enalapril Market Facts & Figures by Country
  35. 5.7.1 South America Enalapril Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Enalapril Sales by Country (2021-2032)
  37. 5.7.3 South America Enalapril Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Enalapril Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Enalapril Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Enalapril Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Enalapril Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Enalapril Sales by Type (2021-2032)
  2. 6.1.1 Global Enalapril Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Enalapril Sales Market Share by Type (2021-2032)
  4. 6.2 Global Enalapril Revenue by Type (2021-2032)
  5. 6.2.1 Global Enalapril Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Enalapril Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Enalapril Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Enalapril Sales by Application (2021-2032)
  2. 7.1.1 Global Enalapril Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Enalapril Sales Market Share by Application (2021-2032)
  4. 7.2 Global Enalapril Revenue by Application (2021-2032)
  5. 7.2.1 Global Enalapril Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Enalapril Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Enalapril Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Enalapril Value Chain Analysis
  2. 8.1.1 Enalapril Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Enalapril Production Mode & Process
  5. 8.2 Enalapril Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Enalapril Distributors
  8. 8.2.3 Enalapril Customers
9 Global Enalapril Analyzing Market Dynamics
  1. 9.1 Enalapril Industry Trends
  2. 9.2 Enalapril Industry Drivers
  3. 9.3 Enalapril Industry Opportunities and Challenges
  4. 9.4 Enalapril Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst